Top Tweets for #CART21

over 4 years ago

⏰ In case you missed it ⏰ During the @TheEBMT #CART21 congress, Jianxiang Wang, @PKU1898, shared the latest advances with #CARTcells in China. Read about the initial data with FasTCAR in R/R #ALL and #myeloma: ready in 1.5 days! #mmsm https://t.co/Q2uVjpkaRl

0

4

1

0

over 4 years ago

⏰ In case you missed it ⏰ CONGRESS | During the 3rd European CAR T-cell Meeting the MM Hub spoke to Sofie Rosanne Terwel. We asked, What is there to know about the EBMT GoCART coalition ❓ #CART21 #mmsm #myeloma https://t.co/B4lvnP5VKd

0

3

1

0

AML Hub

@AML_Hub

almost 5 years ago

📹 Did you see this interview with @Daver_Leukemia @MDAndersonNews? When he spoke to the @AML_Hub during #CART21, we asked, How can we improve efficacy of CAR T-cell therapy in AML? 👉https://t.co/y28bHFtq7X👈 #leusm #leukemia

AML_Hub's tweet photo. 📹 Did you see this interview with @Daver_Leukemia @MDAndersonNews? When he spoke to the @AML_Hub during #CART21, we asked, How can we improve efficacy of CAR T-cell therapy in AML?

👉https://t.co/y28bHFtq7X👈

#leusm #leukemia https://t.co/8RehDdpRNM

0

8

1

0

about 5 years ago

#CART vs. BiTEs in B-cell malignancies w/ @MSubklewe of @LMU_Uniklinikum: https://t.co/dRne1uzJz5 #CART21 @TheEBMT @EHA_Hematology #Leukemia #Leusm #ALLsm #Lymphoma #Lymsm #ImmunoOnc

0

2

0

about 5 years ago

Update on ARI-0001 for patients with CD19+ R/R malignancies, w/ @Manel_JuanOtero (@hospitalclinic): https://t.co/X2LfF2OAUV #CART21 @TheEBMT @EHA_Hematology @immunoclinicbcn #Leukemia #Leusm #ALLsm #CLLsm #CART #ImmunoOnc #Lymphoma #Lymsm

0

2

1

0

Lymphoma Hub

@lymphomahub

about 5 years ago

👀 Have you seen our interview with @drjgauthier ? CONGRESS| #CART21| Watch Jordan Gauthier speak with the @lymphomahub. We asked, When is a second CAR T-cell infusion feasible for patients who failed prior CAR T-cell therapy? 👉 https://t.co/9BvDeLbX1M 👈 #lymphoma #lymsm

lymphomahub's tweet photo. 👀 Have you seen our interview with @drjgauthier ?

CONGRESS| #CART21| Watch Jordan Gauthier speak with the @lymphomahub. We asked, When is a second CAR T-cell infusion feasible for patients who failed prior CAR T-cell therapy?

👉 https://t.co/9BvDeLbX1M 👈

#lymphoma #lymsm https://t.co/nQ4RLeH2ZJ

1

8

3

1

0

about 5 years ago

CAR-Treg therapy for systemic lupus erythematosus, w/ Matteo Doglio (@SanRaffaeleMI): https://t.co/pA4XgIX38Y @TheEBMT @EHA_Hematology #CART21 #ImmunoOnc #CART

0

5

1

0

about 5 years ago

#CART patient experience: results from the Global Patient Survey, w/ @LornaWarwick (@knowyournodes): https://t.co/A19kDj59wp #CART21 @TheEBMT @EHA_Hematology #HemOnc #ImmunoOnc #CellularTherapy

0

5

1

0

VJRegenMed @VJRegenMed

about 5 years ago

CAR-Treg therapy for systemic lupus erythematosus w/ Matteo Doglio of @SanRaffaeleMI: https://t.co/C3hkmYcjzv @VJRegenMed #CART21 @TheEBMT @EHA_Hematology #CARTcell #tcellrx

0

1

0

about 5 years ago

TRUE or FALSE? Test your knowledge on #CARTcells and #bsAB/#BiTEs in multiple #myeloma, alongside a summary of Sébastien Anguille’s presentation at @TheEBMT #CART21 meeting https://t.co/RC3g9ENLTa #mmsm

0

3

4

0

VJRegenMed @VJRegenMed

about 5 years ago

CAR-T in DLBCL: 4-year follow-up data from ZUMA-1 w/ @AnnaSureda5 of @IBECBarcelona: https://t.co/kRW0VSDM2Z @VJRegenMed @TheEBMT @EHA_Hematology #CART21 #CART #HemOnc #Lymsm #DLBCL #tcellrx #CTSM #TrialUpdate #ImmunoOnc #RegenerativeMedicine

0

16

5

0

over 5 years ago

CONGRESS| During the 3rd European CAR T-cell Meeting the @MM_Hub spoke to Sofie Rosanne Terwel. We asked, What is there to know about the EBMT GoCART coalition? https://t.co/B4lvnP5VKd #CART21 #mmsm #myeloma

0

3

1

0

over 5 years ago

CONGRESS |#CART21| Watch Maria Themeli discuss with the @MM_Hub what are the advantages of CAR T-cells derived from pluripotent stem cells? https://t.co/CmvY06grAe @amsterdamumc #myeloma #mmsm

1

6

1

0

VJRegenMed @VJRegenMed

over 5 years ago

CAR T-cells in #Myeloma: patients’ perspective w/ @anandaplate of @MyelomaEurope: https://t.co/ejVh3afOVX @VJRegenMed #CART21 @TheEBMT @EHA_Hematology #HemOnc #MultipleMyeloma #MMsm #CART #ImmunoOnc #tcellrx #RegenerativeMedicine

0

7

2

0

over 5 years ago

The future of #CART therapy in #Lymphoma, w/ @AnnaSureda5 from @ICOnoticies: https://t.co/sW9Xl0dSwd #IAMRESILIENT2021 #Lymsm #ImmunoOnc #tcellrx #cellulartherapy #CART21 @TheEBMT @EHA_Hematology

0

22

8

0

Lymphoma Hub

@lymphomahub

over 5 years ago

Watch Marion Subklewe @MSubklewe from Ludwig-Maximilians-Universität München speaking to the @lymphomahub during #CART21. We asked, Will CAR T-cell therapy change the treatment landscape for MCL? https://t.co/xNdhoW2tnP #lymsm #lymphoma

lymphomahub's tweet photo. Watch Marion Subklewe @MSubklewe from Ludwig-Maximilians-Universität München speaking to the @lymphomahub during #CART21. We asked, Will CAR T-cell therapy change the treatment landscape for MCL? https://t.co/xNdhoW2tnP #lymsm #lymphoma https://t.co/7q43M572sJ

0

5

1

0